While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best High Volume Penny Stocks to Buy. On December 17, Priyanka Grover from J.P. Morgan upgraded Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX ...

Some AI-focused companies are not worth the trouble.

We need a definition that aligns AI development with India’s legal and disability jurisprudence, so that “AI for all” does ...

For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Here is a recap of what happened in the search forums today, through the eyes of the Search Engine Roundtable and other search forums on the web. Google launched Personal Intelligence in AI Mode ...

Health Discovery Corp. advanced stock charts by Barron's. View HDVY historical stock data and compare to other stocks, and exchanges.